Zealand Pharma Feed

Land	Danmark
Lista	Mid Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2020-05-22 22:15:00 Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia

2020-05-22 18:55:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

2020-05-14 15:00:00 Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and accelerates readiness of U.S. commercial operations: Interim report for Q1 2020 -6,49% | 43,2 MDKK

2020-04-30 18:00:00 Total number of shares and voting rights in Zealand Pharma at April 30, 2020 -3,05% | 13,9 MDKK

2020-04-29 15:31:00 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants -1,55% | 33,5 MDKK

2020-04-27 16:30:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +1,43% | 40,6 MDKK

2020-04-20 20:39:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +1,84% | 53,5 MDKK

2020-04-20 20:36:47 Zealand Pharma hosts conference call on May 14 at 4 pm CEST (10 am EDT) to present first quarter results for 2020 +1,84% | 53,5 MDKK

2020-04-15 22:18:35 Zealand Pharma grants warrants and restricted stock units under the employee warrant program and management long-term incentive program +3,83% | 107 MDKK

2020-04-15 17:30:00 Zealand Pharma presents positive clinical and health economic outcome data with use of regular human insulin delivered by the V-Go in adults with type 2 diabetes +3,83% | 107 MDKK

2020-04-15 09:17:04 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants -4,55% | 54,4 MDKK

2020-04-08 12:17:38 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons -2,76% | 25,4 MDKK

2020-04-06 11:42:46 Zealand Pharma major shareholder announcement: Wellington Management Group LLP +5,16% | 46,7 MDKK

2020-04-03 11:57:07 Zealand Pharma’s Annual General Meeting 2020 -1,57% | 26,1 MDKK

2020-04-02 14:38:00 Zealand Pharma completes the acquisition of Valeritas -0,91% | 51,1 MDKK

2020-04-02 11:35:00 Zealand Pharma provides business update related to current COVID-19 situation -0,91% | 51,1 MDKK

2020-03-31 22:40:25 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons -6,42% | 55,4 MDKK

2020-03-31 18:00:00 Total number of shares and voting rights in Zealand Pharma at March 31, 2020 -6,42% | 55,4 MDKK

2020-03-31 15:45:18 Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia +12,09% | 86,6 MDKK

2020-03-31 10:16:37 Zealand Pharma completes subscription of New Ordinary Shares and registration of capital increase +12,09% | 86,6 MDKK

2020-03-30 13:32:00 Zealand Pharma announces positive topline results from Phase 2 trial with dasiglucagon in individuals who have undergone bariatric surgery +6,98% | 71,7 MDKK

2020-03-27 00:25:00 Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 137,236,000 +1,09% | 23,1 MDKK

2020-03-24 22:16:50 Annual General Meeting of Zealand Pharma A/S: Measures in consequence of COVID-19 +1,48% | 45,4 MDKK

2020-03-20 22:17:00 Zealand Pharma regains worldwide rights to Amylin analog program from Boehringer Ingelheim -13,00% | 68,1 MDKK

2020-03-20 15:26:53 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +4,53% | 307 MDKK

2020-03-20 09:54:27 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +4,53% | 307 MDKK

2020-03-11 22:55:00 Zealand Pharma convenes its Annual General Meeting 2020 -19,86% | 83,0 MDKK

2020-03-11 22:50:00 Zealand Pharma advances pipeline and maintains strong cash position: full year results for 2019 -19,86% | 83,0 MDKK

2020-03-09 13:26:24 Update: Zealand Pharma hosts conference call on March 12 at 4 pm CET (11 am EDT) to present full year results for 2019 -5,30% | 79,6 MDKK

2020-02-27 08:00:00 Zealand Pharma to attend Credit Suisse 2020 Global Healthcare Conference -7,31% | 69,3 MDKK

2020-02-26 09:14:42 Zealand Pharma hosts conference call on March 12 at 4 pm CET (10 am EST) to present full year results for 2019 -0,38% | 82,7 MDKK

2020-02-20 19:30:00 Zealand Pharma to attend 9th Annual SVB Leerink Global Healthcare Conference -1,48% | 47,6 MDKK

2020-02-11 13:35:00 Zealand Pharma major shareholder announcement: Wellington Management Group LLP +3,96% | 31,5 MDKK

2020-02-10 02:40:00 Zealand Pharma announces bid to acquire Valeritas +0,31% | 21,6 MDKK

2019-12-31 18:00:00 Total number of shares and voting rights in Zealand Pharma at December 31, 2019 -2,38% | 37,9 MDKK

2019-12-13 15:30:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +0,76% | 36,5 MDKK

2019-12-13 15:00:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +0,76% | 36,5 MDKK

2019-12-11 12:30:00 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants -2,98% | 30,3 MDKK

2019-12-10 18:00:00 Financial calendar for Zealand Pharma in 2020 -2,98% | 30,3 MDKK

2019-12-10 08:00:00 Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System +6,13% | 56,0 MDKK

2019-12-05 17:16:28 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +0,57% | 27,9 MDKK

2019-12-05 11:00:00 Zealand Pharma grants new warrants under the employee warrant program -4,73% | 48,7 MDKK

2019-12-04 14:55:19 Zealand Pharma initiates second Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism +7,95% | 65,5 MDKK

2019-11-29 18:00:00 Total number of shares and voting rights in Zealand Pharma at November 30, 2019 -2,97% | 27,8 MDKK

2019-11-27 15:05:00 Notification of managers and closely related parties’ transactions with Zealand Pharma shares in connection with employee warrant program -0,66% | 30,2 MDKK

2019-11-22 13:00:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +2,49% | 44,2 MDKK

2019-11-14 15:00:00 Zealand Pharma completes Phase 3 clinical program for HypoPal® rescue pen, initiates a new Phase 2 clinical proof of concept trial with dasiglucagon, and secures DKK 560 million in additional investment +4,94% | 88,0 MDKK

2019-10-28 17:00:00 Zealand Pharma hosts conference call on November 14 at 4 PM CET (10 AM ET) to present third quarter results for 2019 +0,49% | 21,7 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2020-11-12	Kvartalsrapport 2020-Q3
2020-08-13	Kvartalsrapport 2020-Q2
2020-05-14	Kvartalsrapport 2020-Q1
2020-04-03	Ordinarie utdelning ZEAL 0.00 DKK
2020-04-02	Årsstämma 2019
2020-03-12	Bokslutskommuniké 2019
2019-11-14	Kvartalsrapport 2019-Q3
2019-08-15	Kvartalsrapport 2019-Q2
2019-05-16	Kvartalsrapport 2019-Q1
2019-04-05	Ordinarie utdelning ZEAL 0.00 DKK
2019-04-04	Årsstämma 2018
2019-03-07	Bokslutskommuniké 2018
2018-11-15	Kvartalsrapport 2018-Q3
2018-08-16	Kvartalsrapport 2018-Q2
2018-05-16	Kvartalsrapport 2018-Q1
2018-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2018-04-19	Årsstämma 2017
2018-03-07	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-24	Kvartalsrapport 2017-Q2
2017-05-17	Kvartalsrapport 2017-Q1
2017-04-06	Ordinarie utdelning ZEAL 0.00 DKK
2017-04-05	Årsstämma 2016
2017-03-15	Bokslutskommuniké 2016
2016-11-09	Kvartalsrapport 2016-Q3
2016-08-25	Kvartalsrapport 2016-Q2
2016-05-18	Kvartalsrapport 2016-Q1
2016-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2016-04-19	Årsstämma 2015
2016-03-16	Bokslutskommuniké 2015
2015-11-05	Kvartalsrapport 2015-Q3
2015-08-28	Kvartalsrapport 2015-Q2
2015-05-22	Kvartalsrapport 2015-Q1
2015-04-22	Ordinarie utdelning ZEAL 0.00 DKK
2015-04-21	Årsstämma 2014
2015-03-12	Bokslutskommuniké 2014
2014-03-21	Ordinarie utdelning ZEAL 0.00 DKK
2013-04-30	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-26	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-25	Årsstämma 2011
2011-04-29	Ordinarie utdelning

Zealand Pharma

Beskrivning

Kalender

Zealand Pharma

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Ett Mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden